BRIDGE: Embedding consumer mHealth tools into cardiac rehab

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The BRIDGE trial evaluates whether supplementing traditional center-based cardiac rehabilitation with a consumer-grade mobile health intervention can improve engagement with the program and adherence to healthy lifestyle behaviors. Participants are adults with conditions such as AMI, PCI, CABG, HFrEF, or heart valve procedures who are enrolled in Phase II cardiac rehabilitation. The study compares usual CBCR with a BRIDGE mHealth augmentation to support exercise, risk factor management, education, and behavioral change outside the clinic. Primary aims focus on feasibility, engagement, and preliminary effects on health outcomes relevant to secondary prevention. The intervention leverages accessible digital tools to supplement the core CR components and target barriers to non-attendance and home-based adherence.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adults aged 18 years or older.
2. Enrolled in or referred to Phase II Center-based Cardiac Rehabilitation Program.
3. Have a qualifying cardiovascular diagnosis or event that meets standard eligibility for Phase II Center-based Cardiac Rehabilitation, such as:

   * Acute myocardial infarction
   * Percutaneous coronary intervention
   * Coronary artery bypass graft surgery
   * Chronic heart failure with reduced ejection fraction
   * Heart valve repair or replacement
   * Stable angina
4. Able to ambulate and participate in exercise testing and training as required by the CR program
5. Ability to speak and read in English
6. Willing and able to provide informed consent.
7. Willing to use study-related devices/apps and complete study assessments.

Exclusion Criteria:

1. Not enrolled in or not planning to participate in Phase II Center-based Cardiac Rehabilitation Program.
2. Presence of a medical, cognitive, psychiatric, or physical condition that, in the opinion of the investigators or CR team, would preclude safe participation in the study or adherence to study procedures.
3. Severe cognitive impairment or active psychiatric illness that would interfere with informed consent or study participation.
4. Terminal illness or other serious medical condition that in the judgement of the treating clinician or investigator would likely preclude completion of the study follow-up period. .
5. Current hospice enrollment or residence in a long-term care facility that would preclude participation in the intervention or completion of study follow-up procedures.
6. Currently participating in another behavioral or digital health intervention trial that could confound study outcomes.
7. Inability or unwillingness to use the required mobile devices, applications, or monitoring equipment, if applicable.

Where it's running

• University of Illinois Hospital and Health Sciences System
  Chicago, Illinois, United States Recruiting

Study contacts

• Principal investigator: Spyros Kitsiou, PhD — University of Illinois Chicago
• Study coordinator: Leah Li, MSN, RN
• Email: yli351@uic.edu
• Phone: 13123553519

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Trends and risk factors for adverse events after primary PCI in AMI patients over 20 years

  This study looks at real-world AMI patients who had a primary PCI to see how often serious events happen during a 2-year follow-up and what factors predict them.

  Recruiting Shanghai Zhongshan Hospital · Shanghai · NCT07833995

• Identifying Coronary Plaque Traits with Photon-counting CT and Multimodality Imaging

  This study tests whether advanced imaging can better identify risky artery plaques in people with stable angina.

  Recruiting Queen Mary University of London · London · NCT07864025

• Can 1-Hz rTMS help with heart rhythm and inflammation after a heart attack?

  This trial tests whether daily 1-Hz repetitive transcranial magnetic stimulation can improve heart rate variability and reduce inflammation in people who have had an acute myocardial infarction, compared with a sham procedure.

  Recruiting Beijing Hospital · Beijing, Beijing Municipality · NCT07842770

• SPIKE FLOW endocardial pacing lead safety and performance study

  This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.

  Recruiting at 2 sites FIAB SpA · Acquaviva delle Fonti, Bari and 2 other locations · NCT07820072

• Predict Arrhythmia Risk with Intelligent Software

  Researchers are testing AI-powered predictions to see if clinicians can spot patients at risk for dangerous heart rhythms using bedside ECG data.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07792694

• Cold-region exposure and heart remodeling after PCI

  This study tests whether long-term cold exposure before PCI is linked to worse heart remodeling and outcomes in people with coronary artery disease.

  Recruiting Chinese PLA General Hospital · Beijing, Please Select An Option Below · NCT07773870

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.